Importantly, we showed that the inflammatory cytokine IL-6 is controlled by BMAL-1, and bmal1 plasmid treatment reduced arthritis in CRD mice; not only P-ERK but also matrix-degrading MMP-3, MMP-13, and ADAMTS5 were significantly reduced in the TMJ. This evidence concerns the gene BMAL1 and arthritic joint disease.